Banoxantrone dihydrochloride is a bioreductive prodrug; activated by hypoxia to yield the topoisomerase II inhibitor AQ4. Displays little to no cytotoxic activity against 60 tumor cell lines tested under oxic conditions (IC50 >100 μM). Exhibits anti-tumor efficacy
in vivo
when combined with oxic cell cytotoxins; enhances the anti-tumor effect of cyclophosphamide (Cat. No. 4091) in a mouse tumor model.
Caractéristiques techniques
| Marque | Tocris Bioscience |
|---|
| Réf. B-LABO | BL-RE-160843 |
|---|
| Réf. fabricant | 18738556 |
|---|
| Nom chimique ou matériau | 1,4-Bis[[2-(dimethyloxidoamino)ethyl]amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride |
|---|
| CAS | 252979-56-9 |
|---|
| Plage de pourcentage du dosage | >98% |
|---|
| Quantité | 25 mg |
|---|
| Formule moléculaire | C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>6</sub>.2HCl |
|---|
| Poids de la formule | Observed MW: 517.4 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
